Alebund Pharmaceuticals
5 clinical trials · Sponsor
◉ Watch Alebund Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China (NCT06933472) | Alebund Pharmaceuticals | 2025-06-13 |
| A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients (NCT06666283) | Alebund Pharmaceuticals | 2025-02-27 |
| A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in Healthy Chinese Participants (NCT06308523) | Alebund Pharmaceuticals | 2024-03-18 |
| AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia (NCT07030595) | Alebund Pharmaceuticals | 2023-06-12 |
| A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients (NCT05764590) | Alebund Pharmaceuticals | 2023-02-20 |
Track Alebund Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.